Corporate social responsibility

As a commercial stage pharmaceutical company, it’s important to us that we take our responsibilities seriously. We are constantly rigorous, both in the research and clinical procedures we follow, and in the standards of corporate governance we adopt.

We maintain and enforce clear and effective health and safety policies, minimising risk to all staff and visitors from the hazardous substances our work can sometimes require us to use.

Latest News

Results Announcement for the year ended 30 June 2017

Vernalis plc (LSE: VER) today announces its audited financial results for the year ended 30 June 2017, following the year-end trading update published on 18 July 2017.


Read more ...

At a glance

More information on Vernalis and its pipeline ...

FactsheetNov14 Company fact sheet

Comm thumbnail Explore the pipeline ...

Contact Vernalis

T: 0118 938 0000
F: 0118 938 0001

Contact information
Maps and directions
Contact form

To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. at 1-855-705-9546 and or FDA at 1-800-FDA-1088 or